Business Description
Shanghai Junshi Biosciences, founded in 2012 and headquartered in Shanghai, China, is a pharmaceutical company focused on researching, developing, and bringing to market new medicines. Its portfolio spans treatments for cancer, autoimmune conditions, and other serious diseases, with several drugs already approved and many more in advanced clinical trials. Key approved products address tumors, rheumatoid arthritis, psoriasis, and high cholesterol, while its pipeline includes promising therapies targeting lung cancer, gastrointestinal cancer, and gynecological tumors, among others.
